{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:09:51Z","timestamp":1787065791400,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06433"],"award-info":[{"award-number":["21K06433"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89551-7","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T02:00:03Z","timestamp":1739325603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rapid and sustained antidepressant effects of tubastatin A in a mouse model of depression"],"prefix":"10.1038","volume":"15","author":[{"given":"Masahide","family":"Fukada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"89551_CR1","unstructured":"WHO. World Health Organization, facts sheets: depression.  (accessed 31 March 2023); https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression)."},{"key":"89551_CR2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae) (American Psychiatric Pub, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"89551_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ajp.2017.01.025","volume":"27","author":"J Dean","year":"2017","unstructured":"Dean, J. & Keshavan, M. The neurobiology of depression: an integrated view. Asian J. Psychiatr.  27, 101\u2013111 (2017).","journal-title":"Asian J. Psychiatr"},{"key":"89551_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/neu.2017.39","volume":"30","author":"VS Pereira","year":"2018","unstructured":"Pereira, V. S. & Hiroaki-Sato, V. A. A brief history of antidepressant drug development: from tricyclics to beyond ketamine. Acta Neuropsychiatr.  30, 307\u2013322 (2018).","journal-title":"Acta Neuropsychiatr"},{"key":"89551_CR5","doi-asserted-by":"publisher","first-page":"e30924","DOI":"10.1371\/journal.pone.0030924","volume":"7","author":"M Fukada","year":"2012","unstructured":"Fukada, M. et al. Loss of deacetylation activity of Hdac6 affects emotional behavior in mice. PLoS One  7, e30924 (2012).","journal-title":"PLoS One"},{"key":"89551_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417, 455\u2013458 (2002).","journal-title":"Nature"},{"key":"89551_CR7","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1128\/MCB.00393-07","volume":"27","author":"YS Gao","year":"2007","unstructured":"Gao, Y. S. et al. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis. Mol. Cell. Biol. 27, 8637\u20138647 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"89551_CR8","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","volume":"27","author":"JP Dompierre","year":"2007","unstructured":"Dompierre, J. P. et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation. J. Neurosci. 27, 3571\u20133583 (2007).","journal-title":"J. Neurosci."},{"key":"89551_CR9","doi-asserted-by":"publisher","first-page":"e10848","DOI":"10.1371\/journal.pone.0010848","volume":"5","author":"S Chen","year":"2010","unstructured":"Chen, S., Owens, G. C., Makarenkova, H. & Edelman, D. B. HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One  5, e10848 (2010).","journal-title":"PLoS One"},{"key":"89551_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","volume":"115","author":"Y Kawaguchi","year":"2003","unstructured":"Kawaguchi, Y. et al. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727\u2013738 (2003).","journal-title":"Cell"},{"key":"89551_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nature05853","volume":"447","author":"UB Pandey","year":"2007","unstructured":"Pandey, U. B. et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859\u2013863 (2007).","journal-title":"Nature"},{"key":"89551_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/emboj.2009.405","volume":"29","author":"JY Lee","year":"2010","unstructured":"Lee, J. Y. et al. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 29, 969\u2013980 (2010).","journal-title":"EMBO J."},{"key":"89551_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","volume":"18","author":"JJ Kovacs","year":"2005","unstructured":"Kovacs, J. J. et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell. 18, 601\u2013607 (2005).","journal-title":"Mol. Cell."},{"key":"89551_CR14","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1523\/JNEUROSCI.5634-11.2012","volume":"32","author":"J Espallergues","year":"2012","unstructured":"Espallergues, J. et al. HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience. J. Neurosci. 32, 4400\u20134416 (2012).","journal-title":"J. Neurosci."},{"key":"89551_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2014.07.036","volume":"77","author":"J Jochems","year":"2015","unstructured":"Jochems, J. et al. Enhancement of stress resilience through histone deacetylase 6-mediated regulation of glucocorticoid receptor chaperone dynamics. Biol. Psychiatr.  77, 345\u2013355 (2015).","journal-title":"Biol. Psychiatry"},{"key":"89551_CR16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuropharm.2016.08.018","volume":"110","author":"M Fukada","year":"2016","unstructured":"Fukada, M., Nakayama, A., Mamiya, T., Yao, T. P. & Kawaguchi, Y. Dopaminergic abnormalities in Hdac6-deficient mice. Neuropharmacology 110, 470\u2013479 (2016).","journal-title":"Neuropharmacology"},{"key":"89551_CR17","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","volume":"10","author":"L Francelle","year":"2020","unstructured":"Francelle, L., Outeiro, T. F. & Rappold, G. A. Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity. Sci. Rep. 10, 6064 (2020).","journal-title":"Sci. Rep."},{"key":"89551_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/npp.2013.207","volume":"39","author":"J Jochems","year":"2014","unstructured":"Jochems, J. et al. Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability. Neuropsychopharmacology 39, 389\u2013400 (2014).","journal-title":"Neuropsychopharmacology"},{"key":"89551_CR19","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1210\/en.2009-1436","volume":"151","author":"IN Karatsoreos","year":"2010","unstructured":"Karatsoreos, I. N. et al. Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 151, 2117\u20132127 (2010).","journal-title":"Endocrinology"},{"key":"89551_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.pnpbp.2010.03.005","volume":"34","author":"EY Sterner","year":"2010","unstructured":"Sterner, E. Y. & Kalynchuk, L. E. Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: relevance to depression. Prog. Neuropsychopharmacol. Biol. Psychiatr.  34, 777\u2013790 (2010).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"89551_CR21","doi-asserted-by":"publisher","first-page":"pyv062","DOI":"10.1093\/ijnp\/pyv062","volume":"18","author":"Y Ago","year":"2015","unstructured":"Ago, Y. et al. The female encounter test: a novel method for evaluating reward-seeking behavior or motivation in mice. Int. J. Neuropsychopharmacol. 18, pyv062 (2015).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"89551_CR22","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt, R. D., Bertin, A. & Jalfre, M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327\u2013336 (1977).","journal-title":"Arch. Int. Pharmacodyn Ther."},{"key":"89551_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00213-004-1815-9","volume":"175","author":"DH Overstreet","year":"2004","unstructured":"Overstreet, D. H., Hlavka, J., Feighner, J. P., Nicolau, G. & Freed, J. S. Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression. Psychopharmacol. (Berl)  175, 303\u2013309 (2004).","journal-title":"Psychopharmacol. (Berl)"},{"key":"89551_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02245592","volume":"121","author":"MJ Detke","year":"1995","unstructured":"Detke, M. J., Rickels, M. & Lucki, I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacol. (Berl)  121, 66\u201372 (1995).","journal-title":"Psychopharmacol. (Berl)"},{"key":"89551_CR25","unstructured":"Franklin, K. B. J. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates,  978-0-12-369460-7. (2008)."},{"key":"89551_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1046\/j.1471-4159.2001.00300.x","volume":"77","author":"Y Dwivedi","year":"2001","unstructured":"Dwivedi, Y. et al. Reduced activation and expression of ERK1\/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J. Neurochem.  77, 916\u2013928 (2001).","journal-title":"J. Neurochem"},{"key":"89551_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.biopsych.2007.07.016","volume":"63","author":"SL Gourley","year":"2008","unstructured":"Gourley, S. L. et al. Regionally-specific regulation of pERK1\/2 MAP kinase in a model of antidepressant-sensitive chronic depression. Biol. Psychiatr. 63, 353\u2013359 (2008).","journal-title":"Biol. Psychiatry"},{"key":"89551_CR28","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1007\/s12035-019-1524-3","volume":"56","author":"JQ Wang","year":"2019","unstructured":"Wang, J. Q. & Mao, L. The ERK pathway: molecular mechanisms and treatment of depression. Mol. Neurobiol. 56, 6197\u20136205 (2019).","journal-title":"Mol. Neurobiol."},{"key":"89551_CR29","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","volume":"22","author":"Y Shirayama","year":"2002","unstructured":"Shirayama, Y., Chen, A. C., Nakagawa, S., Russell, D. S. & Duman, R. S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251\u20133261 (2002).","journal-title":"J. Neurosci."},{"key":"89551_CR30","doi-asserted-by":"publisher","first-page":"8881","DOI":"10.1073\/pnas.92.19.8881","volume":"92","author":"AA Reszka","year":"1995","unstructured":"Reszka, A. A., Seger, R., Diltz, C. D., Krebs, E. G. & Fischer, E. H. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc. Natl. Acad. Sci. USA  92, 8881\u20138885 (1995).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"89551_CR31","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1083\/jcb.105.5.2167","volume":"105","author":"E Schulze","year":"1987","unstructured":"Schulze, E., Asai, D. J., Bulinski, J. C. & Kirschner, M. Posttranslational modification and microtubule stability. J. Cell. Biol. 105, 2167\u20132177 (1987).","journal-title":"J. Cell. Biol."},{"key":"89551_CR32","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","volume":"59","author":"EJ Nestler","year":"2006","unstructured":"Nestler, E. J. & Carlezon, W. A. Jr The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry. 59, 1151\u20131159 (2006).","journal-title":"Biol. Psychiatry"},{"key":"89551_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","volume":"131","author":"V Krishnan","year":"2007","unstructured":"Krishnan, V. et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131, 391\u2013404 (2007).","journal-title":"Cell"},{"key":"89551_CR34","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1523\/JNEUROSCI.2702-13.2014","volume":"34","author":"T Fieblinger","year":"2014","unstructured":"Fieblinger, T. et al. Mechanisms of dopamine D1 receptor-mediated ERK1\/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5. J. Neurosci. 34, 4728\u20134740 (2014).","journal-title":"J. Neurosci."},{"key":"89551_CR35","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1523\/JNEUROSCI.20-05-01849.2000","volume":"20","author":"G Cai","year":"2000","unstructured":"Cai, G., Zhen, X., Uryu, K. & Friedman, E. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J. Neurosci. 20, 1849\u20131857 (2000).","journal-title":"J. Neurosci."},{"key":"89551_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1523\/JNEUROSCI.1802-19.2019","volume":"40","author":"N Prakash","year":"2020","unstructured":"Prakash, N. et al. Serotonergic plasticity in the dorsal raphe nucleus characterizes susceptibility and resilience to anhedonia. J. Neurosci. 40, 569\u2013584 (2020).","journal-title":"J. Neurosci."},{"key":"89551_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","volume":"463","author":"SE File","year":"2003","unstructured":"File, S. E. & Seth, P. A review of 25 years of the social interaction test. Eur. J. Pharmacol. 463, 35\u201353 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"89551_CR38","doi-asserted-by":"crossref","unstructured":"Villas-Boas, G. R. et al. : Modulation of the serotonergic receptosome in the treatment of anxiety and depression: a narrative review of the experimental evidence. Pharmaceuticals (Basel) 14. (2021).","DOI":"10.3390\/ph14020148"},{"key":"89551_CR39","doi-asserted-by":"publisher","first-page":"172876","DOI":"10.1016\/j.pbb.2020.172876","volume":"191","author":"R Yokoyama","year":"2020","unstructured":"Yokoyama, R. et al. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression. Pharmacol. Biochem. Behav. 191, 172876 (2020).","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6436","key":"89551_CR40","doi-asserted-by":"publisher","first-page":"eaat8078","DOI":"10.1126\/science.aat8078","volume":"364","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava, R. N. et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 364 (6436), eaat8078 (2019).","journal-title":"Science"},{"key":"89551_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos, P. et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533, 481\u2013486 (2016).","journal-title":"Nature"},{"key":"89551_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01864-5","author":"X Li","year":"2022","unstructured":"Li, X. et al. Ketamine impairs growth cone and synaptogenesis in human GABAergic projection neurons via GSK-3\u03b2 and HDAC6 signaling. Mol. Psychiatr.  https:\/\/doi.org\/10.1038\/s41380-022-01864-5 (2022).","journal-title":"Mol. Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89551-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89551-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T02:00:11Z","timestamp":1739325611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89551-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89551"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89551-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5182"}}